Author:
Ketch Courtney,Weedin Elizabeth,Gibson Bree Anna
Publisher
Springer International Publishing
Reference9 articles.
1. Beral V, Doll R, Hermon C, Peto R, Reeves G. Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls. Lancet. 2008;371(9609):303–14. doi:10.1016/S0140-6736(08)60167-1.
2. Committee on Gynecologic Practice and the American Society for Reproductive Medicine Practice Committee. Committee Opinion no. 532: Compound Bioidentical Menopausal Hormone therapy. Obster Gynecol 2012.
3. Committee on Practice Bulletins-Gynecology. Practice, bulletin no 141: management of menopausal symptoms. Obster Gynecol. 2014;123(1):202–16.
4. Drewe J, Bucher K, Zahner C. A systematic review of non-hormonal treatments of vasomotor symptoms in climacteric and cancer patients. SpringerPlus. 2015;4(65):1–29. doi:10.1186/s40064-015-0808-y.
5. Fugate S, Church C. Nonestrogen treatment modalities for vasomotor symptoms associated with menopause. Ann Pharmacother. 2004;38:1482–99. doi:10.1345/aph.1D610.